Table 2.

Summary of linear regression analyses for components of therapeutic alliance as a predictor of follow-up well-being scores in participants with elevated depressive symptoms at baseline

	Follow-up well-being
Predictors	b	β	SE	95% CI	P	R2	ΔR2
(Intercept)	12.60	0.002	5.83	1.15–24.06	0.03
Age	0.03	0.01	0.08	− 0.13 to 0.19	0.70
Sex (male)	0.04	0.002	1.50	− 2.91 to 2.99	0.98
Time in care	− 0.01	− 0.03	0.01	− 0.03 to 0.01	0.42
Baseline well-being	0.66	0.23	0.10	0.45 to 0.86	< 0.001	0.05
Components of Therapeutic Alliance Score	2.04	0.08	0.99	0.09–3.99	0.04	0.06	0.01

n = 675. The components of therapeutic alliance scores were measured with adapted items representing the bonds and goals components from the Working Alliance Inventory. Well-being was measured with the WHO-5. Time in care is the number of days between first and last visits

unstandardized regression coefficient; β standardized regression coefficient, SE standard error, CI confidence interval, R2 variance explained in the outcome, ΔR2 incremental variance explained in the outcome